This inventor holds 4 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 2 EPO patents. Top assignee: United Kingdom Research and Innovation. Active years: 2021-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2022
Title: Innovations by Anna Gudny Sigurdardottir
Introduction
Anna Gudny Sigurdardottir is a prominent inventor based in Cambridge, GB. She has made significant contributions to the field of biochemistry, particularly in the development of methods for discovering selective phosphatase inhibitors. With a total of four patents to her name, her work is recognized for its potential therapeutic applications.
Latest Patents
One of her latest patents focuses on methods for selecting phosphatase selective and non-selective phosphatase inhibitors. This invention discloses a method to discover selective inhibitors of phosphatases. The method involves screening a test compound to determine whether it binds to a holophosphatase selectively or non-selectively. The process includes providing two different holophosphatases and comparing the binding of the test compound to each. Another notable patent relates to inhibitors of PPP1 R15A and PPP1 R15B, which are used in therapy for diseases associated with the accumulation of misfolded proteins.
Career Highlights
Anna works at United Kingdom Research and Innovation, where she continues to advance her research and innovations. Her work has garnered attention for its implications in treating various disorders, showcasing her commitment to improving health outcomes through scientific discovery.
Collaborations
She collaborates with esteemed colleagues, including Anne Bertolotti and Indrajit Das, who contribute to her research endeavors and enhance the impact of her inventions.
Conclusion
Anna Gudny Sigurdardottir is a trailblazer in her field, with her innovative patents paving the way for advancements in therapeutic applications. Her contributions are vital to the ongoing research in biochemistry and medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
